Sealife Pharma

Austria
Tulln, Lower Austria, Austria, 3430

Company profile

Sealife Pharma company profile

Sealife is a leading marine biopharma company pioneering the discovery and development of novel biochemistry isolated from the under-explored biological diversity of marine fungi. Their core focus is to develop novel antibiotics to treat multi-drug resistant Gram negative and Gram positive infections e.g. Pseudomonas aeruginosa, Acinetobacter baumanii, Penicillin resistant Streptococci pneumoniae (PRSP), MRSA and Vancomycin resistant enterococci (VRE). In addition, Sealife has discovery and development activities in the development of antimicrobials and disinfection agents.

Business identity

Contact email
[email protected]
Phone number
+43 664 2443774
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2008-01-01, Year

Headquarters

Postal code
3430
Country code
AT
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Seed / 2011-03-04
Last equity funding
Seed
Investors
2
Lead investors
1

Founders and investors

Lead investors

tecnet equity

Investors

PP Capitaltecnet equity